Our core team consists of highly experienced neuroscientists specialising in preclinical neuroimaging. We have extensive experience in using this technique to provide solutions to the pharmaceutical industry. In addition, we count on a team of experts who are committed to providing the best quality results and insights to our clients. At L&M we are constantly striving to stay ahead of the curve and develop innovative solutions to help our clients achieve their goals.
Our CEO and co-founder has a double degree in medicine and aerospace engineering. With over 20 years experience with functional neuroimaging, Michel has worked both in industry and academia. He has a passion for developing innovative practical solutions, always with simplicity as a main approach.
Our COO and co-founder has a degree in biochemistry and is a specialist in drug addictions. Loreto has large experience managing and executing scientific research and has worked in a number of contracts with pharmaceutical companies. Her organisational skills are essential to keep our projects on time and on budget.
Diana has over 20 years of experience in neuroimaging research and has been the director of the BRAIN Centre, King’s College London, since its inception in 2017. Diana and our colleagues at The BRAIN Centre are at the forefront of preclinical functional neuroimaging in drug discovery.
Steve is the Founder, Director and Head of the Centre for Neuroimaging Sciences based at the Institute of Psychiatry and Maudsley Hospital, King’s College London. His recent work has focused on the translation of imaging techniques from bench to bedside with an ever-increasing emphasis on the development of new tools for diagnosis and prediction of response to treatment.
